This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Company News for Nov 13, 2025
by Zacks Equity Research
Companies in The News Are: LEGN, ONON, PLTR, ALC
ALC's Q3 Earnings Beat, Revenues Miss, Stock Rises in After-Market Hours
by Zacks Equity Research
Alcon posts mixed Q3 results as earnings top estimates but revenues miss; new product launches fuel optimism.
Alcon (ALC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Alcon (ALC) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Mettler-Toledo Q3 Earnings Top Estimates, Sales Decline Y/Y
by Zacks Equity Research
MTD posted stronger-than-expected Q3 results, lifted by segment growth and solid guidance for 2025 and 2026.
SOLV Gains on Q3 Earnings & Sales Beat, Raises '25 EPS Outlook
by Zacks Equity Research
Solventum posts strong Q3 results with a revenue and earnings beat, lifts 2025 EPS guidance on solid MedSurg and HIS growth.
XRAY Stock Declines on Q3 Earnings Miss & Lower 2025 EPS View
by Indrajit Bandyopadhyay
DENTSPLY SIRONA shares drop as Q3 earnings miss estimates and 2025 EPS guidance is cut amid segment weakness.
Curious about Alcon (ALC) Q3 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Alcon (ALC) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Avanos Medical Gains on Q3 Earnings Beat, Raises '25 Sales View
by Zacks Equity Research
Avanos Medical posts a Q3 earnings and sales beat, boosts 2025 outlook as Specialty Nutrition drives solid double-digit growth.
MCK Q2 Earnings Beat, Sales Miss, '26 EPS View Up, Stock Down
by Zacks Equity Research
McKesson posts a strong Q2 earnings beat but a slight sales miss, lifts its 2026 EPS outlook on solid specialty and tech segment growth.
Waters Q3 Earnings Surpass Estimates, Revenue Increase Y/Y
by Zacks Equity Research
WAT posts strong Q3 results with 16% earnings growth and higher sales, lifting its full-year outlook for 2025.